Dermatomyositis is a rare autoimmune disease that typically affects the skin, muscle and respiratory system. Patients with dermatomyositis usually require prompt treatment with intense ...

NEW ORLEANS — A monoclonal antibody targeting interferon beta (IFN-beta) provided substantial reductions in the skin lesions associated with dermatomyositis in a double-blind, placebo-controlled phase ...

Dermatomyositis (DM) is a chronic autoimmune disease characterized by inflammatory myopathy and distinctive skin manifestations, significantly affecting patients' quality of life. Dazukibart, a novel ...

—These investigators explored how knowing the distinctive features of dermatomyositis in Black adults, which may be subtle, could possibly lead to faster and more accurate diagnosis. Dermatomyositis ...

The FDA grants Priority Review to brepocitinib for dermatomyositis after trial results show significant muscle and skin improvements in patients.

Immune-boosting herbs may trigger dermatomyositis through different immune pathways, with lower autoantibody rates observed in users. Spirulina is commonly associated with autoimmune disease flares, ...

An investigational monoclonal antibody targeting interferon beta (IFNβ) led to rapid and pronounced reductions in disease activity in adults with dermatomyositis, a randomized phase II study showed.

FDA assigns PDUFA target action date in the third quarter of calendar year 2026 with launch expected at the end of September 2026Priority Review ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The phase 3 study will evaluate brepocitinib’s efficacy ...

Classic DM (CDM) presents with pathognomonic cutaneous findings and progressive, symmetric proximal muscle weakness. Cutaneous disease usually precedes the appearance of myositis by 3–6 months in ...

Children with a rare, debilitating muscle disease could benefit from the findings of new research by experts at UCL and Great Ormond Street Hospital (GOSH). For the study, published in Annals ...

Newly issued guidelines for cancer screening in patients with dermatomyositis had 100% sensitivity in a single institution's cohort, though most of the cancers found would have been detected with ...